Citations (120)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Gary L. Pattee, Angela Genge, Philippe Couratier, Christian Lunetta, Gen Sobue, Masashi Aoki, Hiide Yoshino, Carlayne E. Jackson, James Wymer, Alejandro Salah & Sally Nelson. (2023) Oral Edaravone – Introducing a Flexible Treatment Option for Amyotrophic Lateral Sclerosis. Expert Review of Neurotherapeutics 0:0, pages 1-8.
Read now
Read now
James D. Berry, Marie Blanchard, Kerina Bonar, Emma Drane, Molly Murton, Uffe Ploug, Kristen Ricchetti-Masterson, Natasa Savic, Emma Worthington & Terry Heiman-Patterson. (2023) Epidemiology and economic burden of amyotrophic lateral sclerosis in the United States: a literature review. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:5-6, pages 436-448.
Read now
Read now
Hiide Yoshino. (2019) Edaravone for the treatment of amyotrophic lateral sclerosis. Expert Review of Neurotherapeutics 19:3, pages 185-193.
Read now
Read now
Jinsy A. Andrews, Merit E. Cudkowicz, Orla Hardiman, Lisa Meng, Amy Bian, Jacqueline Lee, Andrew A. Wolff, Fady I. Malik & Jeremy M. Shefner. (2018) VITALITY-ALS, a phase III trial of tirasemtiv, a selective fast skeletal muscle troponin activator, as a potential treatment for patients with amyotrophic lateral sclerosis: study design and baseline characteristics. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:3-4, pages 259-266.
Read now
Read now
Vishwambhar Vishnu Bhandare & Amutha Ramaswamy. (2018) The proteinopathy of D169G and K263E mutants at the RNA Recognition Motif (RRM) domain of tar DNA-binding protein (tdp43) causing neurological disorders: A computational study. Journal of Biomolecular Structure and Dynamics 36:4, pages 1075-1093.
Read now
Read now
Svitlana Garbuzova-Davis, Avery Thomson, Crupa Kurien, R. Douglas Shytle & Paul R. Sanberg. (2016) Potential new complication in drug therapy development for amyotrophic lateral sclerosis. Expert Review of Neurotherapeutics 16:12, pages 1397-1405.
Read now
Read now
Dilara Pirhan, Nurşen Yüksel, Esra Emre, Abdulkadir Cengiz & Demir Kürşat Yıldız. (2016) Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma. Current Eye Research 41:1, pages 59-69.
Read now
Read now
Radhia Benmohamed, Anthony C. Arvanites, Jinho Kim, Robert J. Ferrante, Richard B. Silverman, Richard I. Morimoto & Donald R. Kirsch. (2011) Identification of compounds protective against G93A-SOD1 toxicity for the treatment of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 12:2, pages 87-96.
Read now
Read now
Daniel J. Amante, Jinho Kim, Samantha T. Carreiro, Andrew C. Cooper, Steven W. Jones, Ting Li, Jennifer P. Moody, Christina K. Edgerly, Olivia L. Bordiuk, Kerry Cormier, Karen Smith, Robert J. Ferrante & James Rusche. (2010) Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice. Amyotrophic Lateral Sclerosis 11:6, pages 520-530.
Read now
Read now
Masahiko Yamamoto, Fumiaki Tanaka, Hiroshi Tatsumi & Gen Sobue. (2008) A strategy for developing effective amyotropic lateral sclerosis pharmacotherapy: from clinical trials to novel pharmacotherapeutic strategies. Expert Opinion on Pharmacotherapy 9:11, pages 1845-1857.
Read now
Read now
Andrew P. Smith & Nancy M. Lee. (2007) Role of zinc in ALS. Amyotrophic Lateral Sclerosis 8:3, pages 131-143.
Read now
Read now
Hiide Yoshino & Akio Kimura. (2006) Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study). Amyotrophic Lateral Sclerosis 7:4, pages 247-251.
Read now
Read now
Kirsten L. Gruis, Devin L. Brown, Kevin J. Weatherwax, Eva L. Feldman & Ronald D. Chervin. (2006) Evaluation of sham non‐invasive ventilation for randomized, controlled trials in ALS. Amyotrophic Lateral Sclerosis 7:2, pages 96-99.
Read now
Read now
Articles from other publishers (107)
Thibault Kervarrec, Giuseppe Lo Bello, Daniel Pissaloux, Franck Tirode, Nicolas Poulalhon, Mahtab Samimi, Aurélie Houlier & Arnaud de la Fouchardière. (2023) GRM1 Gene Fusions as an Alternative Molecular Driver in Blue Nevi and Related Melanomas. Modern Pathology 36:10, pages 100264.
Crossref
Crossref
Sumra Malik, G.A Miana, Athar Ata, Madiha Kanwal, Saima Maqsood, Imran Malik & Zartashia Kazmi. (2023) Synthesis, characterization, in-silico, and pharmacological evaluation of new 2-amino-6‑trifluoromethoxy benzothiazole derivatives. Bioorganic Chemistry 130, pages 106175.
Crossref
Crossref
Cristina Puig, Ana Fernández, Luis Gandía & Antonio G. García. 2023. Handbook of Animal Models in Neurological Disorders. Handbook of Animal Models in Neurological Disorders
81
94
.
Jia Xu, Zhengyu Lu, Hongjing Zhang, Yan Shen & Hong Zhao. (2022) Analysis on Acupoint Selection and Combination for Amyotrophic Lateral Sclerosis Treated with Acupuncture Based on Data Mining. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-9.
Crossref
Crossref
Ryosuke Oki, Yuishin Izumi, Koji Fujita, Ryosuke Miyamoto, Hiroyuki Nodera, Yasutaka Sato, Satoshi Sakaguchi, Hiroshi Nokihara, Kazuaki Kanai, Taiji Tsunemi, Nobutaka Hattori, Yuki Hatanaka, Masahiro Sonoo, Naoki Atsuta, Gen Sobue, Toshio Shimizu, Kazumoto Shibuya, Ken Ikeda, Osamu Kano, Kazuto Nishinaka, Yasuhiro Kojima, Masaya Oda, Kiyonobu Komai, Hitoshi Kikuchi, Nobuo Kohara, Makoto Urushitani, Yoshiaki Nakayama, Hidefumi Ito, Makiko Nagai, Kazutoshi Nishiyama, Daisuke Kuzume, Shun Shimohama, Takayoshi Shimohata, Koji Abe, Tomohiko Ishihara, Osamu Onodera, Sagiri Isose, Nobuyuki Araki, Mitsuya Morita, Kazuyuki Noda, Tatsushi Toda, Hirofumi Maruyama, Hirokazu Furuya, Satoshi Teramukai, Tatsuo Kagimura, Kensuke Noma, Hiroaki Yanagawa, Satoshi Kuwabara, Ryuji Kaji, Yusuke Osaki, Hiroki Yamazaki, Shotaro Haji, Yumi Ishida, Akari Futami, Toshiko Miyamoto, Akiyo Akaishi, Kenshi Takechi, Kazuki Maeda, Shoko Kurisu, Mari Yoshizawa, Nozomu Matsuda, Tomoko Nakazato, Ryoichi Nakamura, Naoki Hayashi, Akihiro Kawata, Hideki Kimura, Kota Bokuda, Akiko Tamura, Chiho Ishida, Michi Kawamoto, Hyo Kim, Jun Kawamata, Shin Hisahara, Yuichi Kimura, Toru Yamashita, Yasuyuki Ohta, Kimihito Arai, Takahiro Takeda, Tomoo Ogawa, Shingo Ikari, Yasunori Ono & Yukio Fujino. (2022) Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis. JAMA Neurology 79:6, pages 575.
Crossref
Crossref
Manpreet Kaur, Rupinder Kaur Sodhi, Vaskuri G.S. Sainaga Jyothi, Veerabomma Haritha Sree, Shubhra, Pankaj Kumar Singh, Neelesh Kumar Mehra, Dharmendra Kumar Khatri, Saurabh Srivastava, Shashi Bala Singh, Jitender Madan & Satish Sardana. 2022. Multifunctional Nanocarriers. Multifunctional Nanocarriers
289
345
.
A. Diana & P. Bongioanni. 2022. Glutamate and Neuropsychiatric Disorders. Glutamate and Neuropsychiatric Disorders
359
380
.
Milena Magalhães Augusto, Roberta Gonçalves da Silva, Mario Emílio Teixeira Dourado Júnior, Juliana Fernandes Godoy, Leonardo Wanderley Lopes & Leandro Pernambuco. (2021) Tongue measurements and pharyngeal residue in amyotrophic lateral sclerosis. Neurodegenerative Disease Management 11:6, pages 459-468.
Crossref
Crossref
Jalil Tavakol-Afshari, Amir Reza Boroumand, Najmeh Kaffash Farkhad, Amir Adhami Moghadam, Sajad Sahab-Negah & Ali Gorji. (2021) Safety and efficacy of bone marrow derived-mesenchymal stem cells transplantation in patients with amyotrophic lateral sclerosis. Regenerative Therapy 18, pages 268-274.
Crossref
Crossref
C. Quarracino, M. Bendersky, R. Rey & G. E. Rodríguez. (2020) Logistics and safety of edaravone treatment for amyotrophic lateral sclerosis: experience in Argentina. Acta Neurologica Belgica 121:6, pages 1519-1523.
Crossref
Crossref
Angelina Blyufer, Sonam Lhamo, Cassey Tam, Iffat Tariq, Thongthai Thavornwatanayong & Shahana Mahajan. (2021) Riluzole: A neuroprotective drug with potential as a novel anti‑cancer agent (Review). International Journal of Oncology 59:5.
Crossref
Crossref
Shamchal Bakavayev, Shirel Argueti, Nachiyappan Venkatachalam, Galit Yehezkel, Alexandra Stavsky, Zeev Barak, Adrian Israelson & Stanislav Engel. (2020) Exposure of β6/β7-Loop in Zn/Cu Superoxide Dismutase (SOD1) Is Coupled to Metal Loss and Is Transiently Reversible During Misfolding. ACS Chemical Neuroscience 12:1, pages 49-62.
Crossref
Crossref
Milena Magalhães Augusto, Roberta Gonçalves da Silva, Luzimara Gláucia Oliveira Rodrigues, Priscila Silva Martins, Mario Emílio Teixeira Dourado Júnior & Leandro Pernambuco. (2021) Fiberoptic endoscopic evaluation of swallowing in patients with amyothrophic lateral sclerosis: an integrative literature review. Revista CEFAC 23:5.
Crossref
Crossref
Marcin Bączyk, Piotr Krutki & Daniel Zytnicki. (2021) Is there hope that transpinal direct current stimulation corrects motoneuron excitability and provides neuroprotection in amyotrophic lateral sclerosis?. Physiological Reports 9:2.
Crossref
Crossref
Sofía Ibarburu, Mariángeles Kovacs, Valentina Varela, Jorge Rodríguez-Duarte, Mariana Ingold, Paulina Invernizzi, Williams Porcal, Ana Paula Arévalo, Karen Perelmuter, Mariela Bollati-Fogolín, Carlos Escande, Gloria V. López, Peter King, Ying Si, Yuri Kwon, Carlos Batthyány, Luis Barbeito & Emiliano Trias. (2020) A Nitroalkene Benzoic Acid Derivative Targets Reactive Microglia and Prolongs Survival in an Inherited Model of ALS via NF-κB Inhibition. Neurotherapeutics 18:1, pages 309-325.
Crossref
Crossref
Jan C. Koch, Josua Kuttler, Fabian Maass, Teresa Lengenfeld, Eirini Zielke, Mathias Bähr & Paul Lingor. (2020) Compassionate Use of the ROCK Inhibitor Fasudil in Three Patients With Amyotrophic Lateral Sclerosis. Frontiers in Neurology 11.
Crossref
Crossref
Alexandre Vallée, Jean-Noël Vallée, Rémy Guillevin & Yves Lecarpentier. (2020) Riluzole: a therapeutic strategy in Alzheimer’s disease by targeting the WNT/β-catenin pathway. Aging 12:3, pages 3095-3113.
Crossref
Crossref
Svitlana Garbuzova-Davis, Robert Shell, Hilmi Mustafa, Surafuale Hailu, Alison E. Willing, Paul R. Sanberg & Cesario V. Borlongan. (2020) Advancing Stem Cell Therapy for Repair of Damaged Lung Microvasculature in Amyotrophic Lateral Sclerosis. Cell Transplantation 29, pages 096368972091349.
Crossref
Crossref
Jordi Caplliure‐Llopis, Thalía Peralta‐Chamba, Sandra Carrera‐Juliá, María Cuerda‐Ballester, Eraci Drehmer‐Rieger, María Mar López‐Rodriguez & Jose Enrique de la Rubia Ortí. (2019) Therapeutic alternative of the ketogenic Mediterranean diet to improve mitochondrial activity in Amyotrophic Lateral Sclerosis (ALS): A Comprehensive Review. Food Science & Nutrition 8:1, pages 23-35.
Crossref
Crossref
Cindy Mendes & Jacinta Serpa. (2019) Metabolic Remodelling: An Accomplice for New Therapeutic Strategies to Fight Lung Cancer. Antioxidants 8:12, pages 603.
Crossref
Crossref
E. Srinivasan & R. Rajasekaran. (2019) Rational design of linear tripeptides against the aggregation of human mutant SOD1 protein causing amyotrophic lateral sclerosis. Journal of the Neurological Sciences 405, pages 116425.
Crossref
Crossref
Joana G Fernandes, Nuno H Franco, Andrew J Grierson, Jan Hultgren, Andrew J W Furley & I Anna S Olsson. (2019) Methodological standards, quality of reporting and regulatory compliance in animal research on amyotrophic lateral sclerosis: a systematic review. BMJ Open Science 3:1, pages e000016.
Crossref
Crossref
Shamchal Bakavayev, Nimrod Chetrit, Tatiana Zvagelsky, Rasha Mansour, Maria Vyazmensky, Zeev Barak, Adrian Israelson & Stanislav Engel. (2019) Cu/Zn-superoxide dismutase and wild-type like fALS SOD1 mutants produce cytotoxic quantities of H2O2 via cysteine-dependent redox short-circuit. Scientific Reports 9:1.
Crossref
Crossref
Hitoshi Warita, Masaaki Kato, Ryuta Asada, Atsuko Yamashita, Daichika Hayata, Kiichi Adachi & Masashi Aoki. (2018) Safety, Tolerability, and Pharmacodynamics of Intrathecal Injection of Recombinant Human HGF (KP‐100) in Subjects With Amyotrophic Lateral Sclerosis: A Phase I Trial. The Journal of Clinical Pharmacology 59:5, pages 677-687.
Crossref
Crossref
Vijay Kumar, Preeti Gupta & Md. Imtaiyaz Hassan. (2019) Mechanism and implications of traditional Chinese medicine in amyotrophic lateral sclerosis therapy. Journal of Proteins and Proteomics.
Crossref
Crossref
Katherine J. RobinsonKristy C. YuanEmily K. DonAlison L. HoganClaire G. WinnickMadelaine C. TymCaitlin W. LucasHamideh ShahheydariMaxinne WatchonIan P. BlairJulie D. AtkinGarth A. NicholsonNicholas J. ColeAngela S. Laird. (2019) Motor Neuron Abnormalities Correlate with Impaired Movement in Zebrafish that Express Mutant Superoxide Dismutase 1. Zebrafish 16:1, pages 8-14.
Crossref
Crossref
Svitlana Garbuzova-Davis, Edward Haller, Stephanie Navarro, Tony E. Besong, Kayla J. Boccio, Surafuale Hailu, Mohammed Khatib, Paul R. Sanberg, Stanley H. Appel & Cesario V. Borlongan. (2018) Transplantation of human bone marrow stem cells into symptomatic ALS mice enhances structural and functional blood-spinal cord barrier repair. Experimental Neurology 310, pages 33-47.
Crossref
Crossref
Kallol Dutta, Priyanka Patel & Jean-Pierre Julien. (2018) Protective effects of Withania somnifera extract in SOD1G93A mouse model of amyotrophic lateral sclerosis. Experimental Neurology 309, pages 193-204.
Crossref
Crossref
Florie Borel, Gwladys Gernoux, Huaming Sun, Rachel Stock, Meghan Blackwood, Robert H. BrownJr.Jr. & Christian Mueller. (2018) Safe and effective superoxide dismutase 1 silencing using artificial microRNA in macaques. Science Translational Medicine 10:465.
Crossref
Crossref
Janice M. Mehnert, Ann W. Silk, J. H. Lee, Liesel Dudek, Byeong-Seon Jeong, Jiadong Li, Jason M. Schenkel, Evita Sadimin, Michael Kane, Hongxia Lin, Weichung J. Shih, Andrew Zloza, Suzie Chen & James S. Goydos. (2018) A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma. Pigment Cell & Melanoma Research 31:4, pages 534-540.
Crossref
Crossref
Svitlana Garbuzova-Davis, Jared Ehrhart, Paul Sanberg & Cesario Borlongan. (2018) Potential Role of Humoral IL-6 Cytokine in Mediating Pro-Inflammatory Endothelial Cell Response in Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 19:2, pages 423.
Crossref
Crossref
Merry W. Ma, Jing Wang, Quanguang Zhang, Ruimin Wang, Krishnan M. Dhandapani, Ratna K. Vadlamudi & Darrell W. Brann. (2017) NADPH oxidase in brain injury and neurodegenerative disorders. Molecular Neurodegeneration 12:1.
Crossref
Crossref
Paul Grant, Cristan Farmer, Jane Song, Timothy Kish & Susan Swedo. (2017) Riluzole Serum Concentration in Pediatric Patients Treated for Obsessive-Compulsive Disorder. Journal of Clinical Psychopharmacology 37:6, pages 713-716.
Crossref
Crossref
Medhi Wangpaichitr, Chunjing Wu, Ying Ying Li, Dan J.M. Nguyen, Hande Kandemir, Sumedh Shah, Shumei Chen, Lynn G. Feun, Jeffrey S. Prince, Macus T. Kuo & Niramol Savaraj. (2017) Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer. Oncotarget 8:30, pages 49275-49292.
Crossref
Crossref
Svitlana Garbuzova-Davis, Crupa Kurien, Avery Thomson, Dimitri Falco, Sohaib Ahmad, Joseph Staffetti, George Steiner, Sophia Abraham, Greeshma James, Ajay Mahendrasah, Paul R. Sanberg & Cesario V. Borlongan. (2017) Endothelial and Astrocytic Support by Human Bone Marrow Stem Cell Grafts into Symptomatic ALS Mice towards Blood-Spinal Cord Barrier Repair. Scientific Reports 7:1.
Crossref
Crossref
Victor Banerjee, Tom Shani, Bella Katzman, Maria Vyazmensky, Niv Papo, Adrian Israelson & Stanislav Engel. (2016) Superoxide Dismutase 1 (SOD1)-Derived Peptide Inhibits Amyloid Aggregation of Familial Amyotrophic Lateral Sclerosis SOD1 Mutants. ACS Chemical Neuroscience 7:11, pages 1595-1606.
Crossref
Crossref
Alexandre Vallée & Yves Lecarpentier. (2016) Alzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and Gamma. Frontiers in Neuroscience 10.
Crossref
Crossref
Shashi K. Verma, Indu Arora, Kalim Javed, Mohd Akhtar & Mohammed Samim. (2016) Enhancement in the Neuroprotective Power of Riluzole Against Cerebral Ischemia Using a Brain Targeted Drug Delivery Vehicle. ACS Applied Materials & Interfaces 8:30, pages 19716-19723.
Crossref
Crossref
Jana Schmidt, Thorsten Schmidt, Matthias Golla, Lisa Lehmann, Jonasz Jeremiasz Weber, Jeannette Hübener-Schmid & Olaf Riess. (2016)
In vivo
assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3
. Journal of Neurochemistry 138:1, pages 150-162.
Crossref
Crossref
Yves Lecarpentier & Alexandre Vallée. (2016) Opposite Interplay between PPAR Gamma and Canonical Wnt/Beta-Catenin Pathway in Amyotrophic Lateral Sclerosis. Frontiers in Neurology 7.
Crossref
Crossref
Valerio Chiurchiù, Antonio Orlacchio & Mauro Maccarrone. (2016) Is Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative Diseases. Oxidative Medicine and Cellular Longevity 2016, pages 1-11.
Crossref
Crossref
Jared Ehrhart, Adam J. Smith, Nicole Kuzmin-Nichols, Theresa A. Zesiewicz, Israt Jahan, R. Douglas Shytle, Seol-Hee Kim, Cyndy D. Sanberg, Tuan H. Vu, Clifton L. Gooch, Paul R. Sanberg & Svitlana Garbuzova-Davis. (2015) Humoral factors in ALS patients during disease progression. Journal of Neuroinflammation 12:1.
Crossref
Crossref
Valentin K. Gribkoff. 2015. The Functions, Disease‐Related Dysfunctions, and Therapeutic Targeting of Neuronal Mitochondria. The Functions, Disease‐Related Dysfunctions, and Therapeutic Targeting of Neuronal Mitochondria
295
321
.
Holly C. Hunsberger, Daniel S. Weitzner, Carolyn C. Rudy, James E. Hickman, Eric M. Libell, Rebecca R. Speer, Greg A. Gerhardt & Miranda N. Reed. (2015) Riluzole rescues glutamate alterations, cognitive deficits, and tau pathology associated with P301L tau expression. Journal of Neurochemistry 135:2, pages 381-394.
Crossref
Crossref
Michael H. Bloch & Eric A. Storch. (2015) Assessment and Management of Treatment-Refractory Obsessive-Compulsive Disorder in Children. Journal of the American Academy of Child & Adolescent Psychiatry 54:4, pages 251-262.
Crossref
Crossref
S Senese, Y C Lo, D Huang, T A Zangle, A A Gholkar, L Robert, B Homet, A Ribas, M K Summers, M A Teitell, R Damoiseaux & J Z Torres. (2014) Chemical dissection of the cell cycle: probes for cell biology and anti-cancer drug development. Cell Death & Disease 5:10, pages e1462-e1462.
Crossref
Crossref
Hyun Young Kim, Heejaung Kim, Ki-Wook Oh, Seong-Il Oh, Seong-Ho Koh, Wonki Baik, Min Young Noh, Kyung Suk Kim & Seung Hyun Kim. (2014) Biological Markers of Mesenchymal Stromal Cells as Predictors of Response to Autologous Stem Cell Transplantation in Patients With Amyotrophic Lateral Sclerosis: An Investigator-Initiated Trial and In Vivo Study. Stem Cells 32:10, pages 2724-2731.
Crossref
Crossref
Uri Nimrod Ramírez-Jarquín, Rafael Lazo-Gómez, Luis B. Tovar-y-Romo & Ricardo Tapia. (2014) Spinal inhibitory circuits and their role in motor neuron degeneration. Neuropharmacology 82, pages 101-107.
Crossref
Crossref
Darren T. Hwee, Adam Kennedy, Julie Ryans, Alan J. Russell, Zhiheng Jia, Aaron C. Hinken, David J. Morgans, Fady I. Malik & Jeffrey R. Jasper. (2014) Fast Skeletal Muscle Troponin Activator tirasemtiv Increases Muscle Function and Performance in the B6SJL-SOD1G93A ALS Mouse Model. PLoS ONE 9:5, pages e96921.
Crossref
Crossref
Cecilia L. Speyer, Ali H. Hachem, Ali A. Assi, Jennifer S. Johnson, John A. DeVries & David H. Gorski. (2014) Metabotropic Glutamate Receptor-1 as a Novel Target for the Antiangiogenic Treatment of Breast Cancer. PLoS ONE 9:3, pages e88830.
Crossref
Crossref
Malathi Banda, Cecilia L. Speyer, Sara N. Semma, Kingsley O. Osuala, Nicole Kounalakis, Keila E. Torres Torres, Nicola J. Barnard, Hyunjin J. Kim, Bonnie F. Sloane, Fred R. Miller, James S. Goydos & David H. Gorski. (2014) Metabotropic Glutamate Receptor-1 Contributes to Progression in Triple Negative Breast Cancer. PLoS ONE 9:1, pages e81126.
Crossref
Crossref
Bernadett Kalmar, Ching-Hua Lu & Linda Greensmith. (2014) The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol. Pharmacology & Therapeutics 141:1, pages 40-54.
Crossref
Crossref
Xue Zhang, Yan-Long Hong, De-Sheng Xu, Yi Feng, Li-Jie Zhao, Ke-Feng Ruan & Xiu-Juan Yang. (2014) A Review of Experimental Research on Herbal Compounds in Amyotrophic Lateral Sclerosis. Phytotherapy Research 28:1, pages 9-21.
Crossref
Crossref
Mark C. Bellingham. (2013) Pre- and postsynaptic mechanisms underlying inhibition of hypoglossal motor neuron excitability by riluzole. Journal of Neurophysiology 110:5, pages 1047-1061.
Crossref
Crossref
M.C. Evans, Y. Couch, N. Sibson & M.R. Turner. (2013) Inflammation and neurovascular changes in amyotrophic lateral sclerosis. Molecular and Cellular Neuroscience 53, pages 34-41.
Crossref
Crossref
Silvia Sorce, Karl-Heinz Krause & Vincent Jaquet. (2012) Targeting NOX enzymes in the central nervous system: therapeutic opportunities. Cellular and Molecular Life Sciences 69:14, pages 2387-2407.
Crossref
Crossref
Massimiliano De Paola, Alessandro Mariani, Paolo Bigini, Marco Peviani, Giovanni Ferrara, Monica Molteni, Sabrina Gemma, Pietro Veglianese, Valeria Castellaneta, Valentina Boldrin, Carlo Rossetti, Chiara Chiabrando, Gianluigi Forloni, Tiziana Mennini & Roberto Fanelli. (2012) Neuroprotective Effects of Toll-Like Receptor 4 Antagonism in Spinal Cord Cultures and in a Mouse Model of Motor Neuron Degeneration. Molecular Medicine 18:6, pages 971-981.
Crossref
Crossref
Cecilia L. Speyer, Jennifer S. Smith, Malathi Banda, John A. DeVries, Tassia Mekani & David H. Gorski. (2011) Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer. Breast Cancer Research and Treatment 132:2, pages 565-573.
Crossref
Crossref
Tian Chen, Radhia Benmohamed, Jinho Kim, Karen Smith, Daniel Amante, Richard I. Morimoto, Donald R. Kirsch, Robert J. Ferrante & Richard B. Silverman. (2011) ADME-Guided Design and Synthesis of Aryloxanyl Pyrazolone Derivatives To Block Mutant Superoxide Dismutase 1 (SOD1) Cytotoxicity and Protein Aggregation: Potential Application for the Treatment of Amyotrophic Lateral Sclerosis. Journal of Medicinal Chemistry 55:1, pages 515-527.
Crossref
Crossref
John Steeves & Andrew Blight. 2012. Spinal Cord Injury. Spinal Cord Injury
386
397
.
Jesse A. Solomon, Alexandro Gianforcaro & Mazen J. Hamadeh. (2011) Vitamin D3 Deficiency Differentially Affects Functional and Disease Outcomes in the G93A Mouse Model of Amyotrophic Lateral Sclerosis. PLoS ONE 6:12, pages e29354.
Crossref
Crossref
Takao Shinozawa, Yoshihiro Urade, Toshihiko Maruyama & Daishi Watabe. (2011) Tetranor PGDM analyses for the amyotrophic lateral sclerosis: Positive and simple diagnosis and evaluation of drug effect. Biochemical and Biophysical Research Communications 415:4, pages 539-544.
Crossref
Crossref
Tommaso Iannitti & Beniamino Palmieri. (2012) Clinical and Experimental Applications of Sodium Phenylbutyrate. Drugs in R&D 11:3, pages 227-249.
Crossref
Crossref
Michael E. Bozik, James L. Mather, William G. Kramer, Valentin K. Gribkoff & Evan W. Ingersoll. (2011) Safety, Tolerability, and Pharmacokinetics of KNS-760704 (Dexpramipexole) in Healthy Adult Subjects. The Journal of Clinical Pharmacology 51:8, pages 1177-1185.
Crossref
Crossref
Kathie Clarke & Todd Levine. (2011) Clinical Recognition and Management of Amyotrophic Lateral Sclerosis. Journal of Neuroscience Nursing 43:4, pages 205-214.
Crossref
Crossref
Deanna Diebold. (2011) Management of Respiratory Complications in Neuromuscular Weakness. Clinical Pulmonary Medicine 18:4, pages 175-180.
Crossref
Crossref
Mark C. Bellingham. (2011) A Review of the Neural Mechanisms of Action and Clinical Efficiency of Riluzole in Treating Amyotrophic Lateral Sclerosis: What have we Learned in the Last Decade?. CNS Neuroscience & Therapeutics 17:1, pages 4-31.
Crossref
Crossref
Ji-Seon Seo, In-Sun Baek, Yea-Hyun Leem, Tae-Kyung Kim, Yearin Cho, Soo Min Lee, Yang Hae Park & Pyung-Lim Han. (2011) SK-PC-B70M alleviates neurologic symptoms in G93A-SOD1 amyotrophic lateral sclerosis mice. Brain Research 1368, pages 299-307.
Crossref
Crossref
Paul D. Wright, Mickey Huang, Alexandra Weiss, Jonathan Matthews, Nicholas Wightman, Marcie Glicksman & Robert H. BrownJr.Jr.. (2010) Screening for inhibitors of the SOD1 gene promoter: Pyrimethamine does not reduce SOD1 levels in cell and animal models. Neuroscience Letters 482:3, pages 188-192.
Crossref
Crossref
Maithao N. Le, Joseph L.-K. Chan, Stephen A. Rosenberg, Adam S. Nabatian, Kim T. Merrigan, Karine A. Cohen-Solal & James S. Goydos. (2010) The Glutamate Release Inhibitor Riluzole Decreases Migration, Invasion, and Proliferation of Melanoma Cells. Journal of Investigative Dermatology 130:9, pages 2240-2249.
Crossref
Crossref
Jung‐Soo Pyo, Young San Ko, Woo Ho Kim, Manho Kim, Kwang‐Woo Lee, Seon Young Nam, Hee‐Yong Chung, Sung Jin Cho, Tai‐Kyoung Baik & Byung Lan Lee. (2010) Impairment of nuclear factor‐κB activation increased glutamate excitotoxicity in a motoneuron–neuroblastoma hybrid cell line expressing mutant (G93A) Cu/Zn‐superoxide dismutase. Journal of Neuroscience Research 88:11, pages 2494-2503.
Crossref
Crossref
Antonio Bastone, Elena Fumagalli, Paolo Bigini, Pietro Perini, Davide Bernardinello, Alfredo Cagnotto, Ilario Mereghetti, Daniela Curti, Mario Salmona & Tiziana Mennini. (2009) Proteomic Profiling of Cervical and Lumbar Spinal Cord Reveals Potential Protective Mechanisms in the Wobbler Mouse, a Model of Motor Neuron Degeneration. Journal of Proteome Research 8:11, pages 5229-5240.
Crossref
Crossref
Dana Yip, Maithao N. Le, Joseph L.-K. Chan, Jonathan H. Lee, Janice A. Mehnert, Anthony Yudd, Jeffery Kempf, Weichung J. Shih, Suzie Chen & James S. Goydos. (2009) A Phase 0 Trial of Riluzole in Patients with Resectable Stage III and IV Melanoma. Clinical Cancer Research 15:11, pages 3896-3902.
Crossref
Crossref
Dagmar E. Ehrnhoefer, Stefanie L. Butland, Mahmoud A. Pouladi & Michael R. Hayden. (2009) Mouse models of Huntington disease: variations on a theme. Disease Models & Mechanisms 2:3-4, pages 123-129.
Crossref
Crossref
Rachel Nardin, Carl O'Donnell, Stephen H Loring, Rui Nie, Kristi Hembre, Joy Walsh, Barbara Wilson Arboleda, Alona Muzikansky, Dang Nguyen & Elizabeth Raynor. (2008) Diaphragm Training in Amyotrophic Lateral Sclerosis. Journal of Clinical Neuromuscular Disease 10:2, pages 56-60.
Crossref
Crossref
Antonio Conti, Sandro Iannaccone, Barbara Sferrazza, Lucia De Monte, Stefano Cappa, Diego Franciotta, Stefano Olivieri & Massimo Alessio. (2008) Differential expression of ceruloplasmin isoforms in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. PROTEOMICS - CLINICAL APPLICATIONS 2:12, pages 1628-1637.
Crossref
Crossref
Hongyun Huang, Lin Chen, Haitao Xi, Hongmei Wang, Jian Zhang, Feng Zhang & Yancheng Liu. (2008) Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study. Clinical Transplantation 22:6, pages 710-718.
Crossref
Crossref
Elsa Raibon, Lisa Marie Todd & Thomas Möller. (2008) Glial Cells in ALS: The Missing Link?. Physical Medicine and Rehabilitation Clinics of North America 19:3, pages 441-459.
Crossref
Crossref
Ya-Jean Wang, Ming-Wei Lin, An-An Lin & Sheng-Nan Wu. (2008) Riluzole-induced block of voltage-gated Na+ current and activation of BKCa channels in cultured differentiated human skeletal muscle cells. Life Sciences 82:1-2, pages 11-20.
Crossref
Crossref
Ying-jun Guan, Xin Wang, Hong-yan Wang, Kyutaro Kawagishi, Hoon Ryu, Chun-feng Huo, Ethan M. Shimony, Bruce S. Kristal, Hans-Georg Kuhn & Robert M. Friedlander. (2007) Increased stem cell proliferation in the spinal cord of adult amyotrophic lateral sclerosis transgenic mice. Journal of Neurochemistry 102:4, pages 1125-1138.
Crossref
Crossref
Mark P. Mattson. (2007) Calcium and neurodegeneration. Aging Cell 6:3, pages 337-350.
Crossref
Crossref
P. Volanti, M. Mannino, T. Piccoli & V. La Bella. (2007) Carcinoma of the tongue and bulbar-onset amyotrophic lateral sclerosis: unusual differential diagnosis. Neurological Sciences 28:3, pages 151-153.
Crossref
Crossref
Rita Sattler & Jeffrey D. Rothstein. (2007) Targeting an Old Mechanism in a New Disease—Protection of Glutamatergic Dysfunction in Depression. Biological Psychiatry 61:2, pages 137-138.
Crossref
Crossref
Christi Kolarcik & Robert Bowser. (2012) Plasma and Cerebrospinal Fluid-Based Protein Biomarkers for Motor Neuron Disease. Molecular Diagnosis & Therapy 10:5, pages 281-292.
Crossref
Crossref
Tiziana Mennini, Massimiliano De Paola, Paolo Bigini, Cristina Mastrotto, Elena Fumagalli, Sara Barbera, Manuela Mengozzi, Barbara Viviani, Emanuela Corsini, Marina Marinovich, Lars Torup, Johan Van Beek, Marcel Leist, Michael Brines, Antony Cerami & Pietro Ghezzi. (2006) Nonhematopoietic Erythropoietin Derivatives Prevent Motoneuron Degeneration In Vitro and In Vivo. Molecular Medicine 12:7-8, pages 153-160.
Crossref
Crossref
Scott Lindhorst & Merit Cudkowicz. (2006) Is pentoxifylline safe and effective in patients with amyotrophic lateral sclerosis?. Nature Clinical Practice Neurology 2:7, pages 364-365.
Crossref
Crossref
Jessica Mandrioli, Daniele Del Rio, Andrea Zini, Paolo Nichelli, Elisa Merelli, Diego Beltrami, Catia Cesari, Nicoletta Pellegrini, Furio Brighenti & Patrizia Sola. (2006) Total antioxidant capacity of cerebrospinal fluid is decreased in patients with motor neuron disease. Neuroscience Letters 401:3, pages 203-208.
Crossref
Crossref
Louis-Etienne Lorenzo, Annick Barbe, Paule Portalier, Jean-Marc Fritschy & Hélène Bras. (2006)
Differential expression of GABA
A
and glycine receptors in ALS-resistant vs. ALS-vulnerable motoneurons: possible implications for selective vulnerability of motoneurons
. European Journal of Neuroscience 23:12, pages 3161-3170.
Crossref
Crossref
P. Cintas. (2006) Quels sont les traitements médicamenteux étiologiques?. Revue Neurologique 162, pages 220-227.
Crossref
Crossref
Maria Teresa Carrì, Giuliano Grignaschi & Caterina Bendotti. (2006) Targets in ALS: designing multidrug therapies. Trends in Pharmacological Sciences 27:5, pages 267-273.
Crossref
Crossref
Mark P. Mattson & Tim Magnus. (2006) Ageing and neuronal vulnerability. Nature Reviews Neuroscience 7:4, pages 278-294.
Crossref
Crossref
Elena Fumagalli, Paolo Bigini, Sara Barbera, Massimiliano De Paola & Tiziana Mennini. (2006) Riluzole, unlike the AMPA antagonist RPR119990, reduces motor impairment and partially prevents motoneuron death in the wobbler mouse, a model of neurodegenerative disease. Experimental Neurology 198:1, pages 114-128.
Crossref
Crossref
Carmelo Sidoti & Umberto Agrillo. (2006) Chronic Cortical Stimulation for Amyotropic Lateral Sclerosis: A Report of Four Consecutive Operated Cases after a 2-Year Follow-up: Technical Case Report. Neurosurgery 58:2, pages E384.
Crossref
Crossref
Lieve Moons, Peter Carmeliet & Mieke Dewerchin. 2006. The Cell Cycle in the Central Nervous System. The Cell Cycle in the Central Nervous System
245
264
.
Alexander Battler & Jonathan LeorYaniv Barkana & Michael Belkin. 2006. Stem Cell and Gene-Based Therapy. Stem Cell and Gene-Based Therapy
237
249
.
Niranjanan Nirmalananthan & Linda Greensmith. (2005) Amyotrophic lateral sclerosis: recent advances and future therapies. Current Opinion in Neurology 18:6, pages 712-719.
Crossref
Crossref
Yvette Akwa, Hervé Allain, Danièle Bentue-Ferrer, Claudine Berr, Régis Bordet, Hugo Geerts, André Nieoullon, Brigitte Onteniente & Martine Vercelletto. (2005) Neuroprotection and Neurodegenerative Diseases. Alzheimer Disease & Associated Disorders 19:4, pages 226-239.
Crossref
Crossref
Eiliv Brenner, Daniel Kondziella, Asta Haberg & Ursula Sonnewald. (2005) Impaired glutamine metabolism in NMDA receptor hypofunction induced by MK801. Journal of Neurochemistry 94:6, pages 1594-1603.
Crossref
Crossref
Hoon Ryu, Karen Smith, Sandra I. Camelo, Isabel Carreras, Junghee Lee, Antonio H. Iglesias, Fernando Dangond, Kerry A. Cormier, Merit E. Cudkowicz, Robert H. BrownJrJr & Robert J. Ferrante. (2005) Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice. Journal of Neurochemistry 93:5, pages 1087-1098.
Crossref
Crossref
Curtis W. NoonanMary C. WhiteDavid ThurmanLee-Yang Wong. (2005) Temporal and geographic variation in United States motor neuron disease mortality, 1969–1998. Neurology 64:7, pages 1215-1221.
Crossref
Crossref
Jennica MC Winhammar, Dominic B Rowe, Robert D Henderson & Matthew C Kiernan. (2005) Assessment of disease progression in motor neuron disease. The Lancet Neurology 4:4, pages 229-238.
Crossref
Crossref
Edith G McGeer & Patrick L McGeer. (2005) Pharmacologic Approaches to the Treatment of Amyotrophic Lateral Sclerosis. BioDrugs 19:1, pages 31-37.
Crossref
Crossref
J. M. GrahamN. PapadakisJ. EvansE. WidjajaC. A.J. RomanowskiM. N.J. PaleyL. I. WallisI. D. WilkinsonP. J. ShawP. D. Griffiths. (2004) Diffusion tensor imaging for the assessment of upper motor neuron integrity in ALS. Neurology 63:11, pages 2111-2119.
Crossref
Crossref
Catherine B. Kunst. (2004) Complex Genetics of Amyotrophic Lateral Sclerosis. The American Journal of Human Genetics 75:6, pages 933-947.
Crossref
Crossref
. (2004) October 26 Highlight and Commentary. Neurology 63:8, pages 1345-1345.
Crossref
Crossref
Da Wei Zang, Qing Yang, Hong Xin Wang, Gary Egan, Elizabeth C Lopes & Surindar S Cheema. (2004) Magnetic resonance imaging reveals neuronal degeneration in the brainstem of the superoxide dismutase 1G93A G1H transgenic mouse model of amyotrophic lateral sclerosis. European Journal of Neuroscience 20:7, pages 1745-1751.
Crossref
Crossref
Erik Storkebaum, Diether Lambrechts & Peter Carmeliet. (2004) VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. BioEssays 26:9, pages 943-954.
Crossref
Crossref